Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Moodys
Argus Health
Mallinckrodt
UBS
Johnson and Johnson
Harvard Business School
Accenture
Daiichi Sankyo

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064106

« Back to Dashboard

NDA 064106 describes MITOMYCIN, which is a drug marketed by Accord Hlthcare, Hospira, Mylan Labs Ltd, and West-ward Pharms Int, and is included in six NDAs. It is available from three suppliers. Additional details are available on the MITOMYCIN profile page.

The generic ingredient in MITOMYCIN is mitomycin. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mitomycin profile page.
Summary for 064106
Tradename:MITOMYCIN
Applicant:Hospira
Ingredient:mitomycin
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength20MG/VIAL
Approval Date:Nov 29, 1995TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
US Army
Medtronic
Accenture
Moodys
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.